https://www.gosh.nhs.uk/our-people/staff-z/andreas-roposch/
Andreas Roposch
He has a particular interest in the treatment of complex hip problems in children and young people including all aspects of disease.
Publications
Reliability of Bucholz and Ogden classification for osteonecrosis secondary to developmental dysplasia of the hip
Roposch A, Wedge JH, Riedl G. 2012 Dec 470(12):3499-505
Functional outcomes in children with osteonecrosis secondary to treatment of developmental dysplasia of the hip
Roposch A, Liu LQ, Offiah AC, Wedge JH. 2011 Dec 21;93(24):e145
Management of slipped capital femoral epiphysis: results of a survey of the members of the European Paediatric Orthopaedic Society
Sonnega RJ, van der Sluijs JA, Wainwright AM, Roposch A, Hefti F. 2011 Dec 5(6):433-8.
Standardized diagnostic criteria for developmental dysplasia of the hip in early infancy
Roposch A, Liu LQ, Hefti F, Clarke NM, Wedge JH. 2011 Dec 469(12):3451-61
More publications from Andreas Roposch.
Specialisms
-
hip disorders in children and young people
-
benign bone tumours
-
osteogenesis imperfecta and childhood osteoporosis
-
skeletal dysplasias
Qualifications
- MD MSc FRCS
- Fellow of the Royal College of Surgeons of England
- MSc in Clinical Epidemiology and Biostatistics (2005)
- Medical Doctorate (1995)
Before joining Great Ormond Street Hospital, Mr Roposch was a Professor of Orthopaedic Surgery and Deputy Clinical Lead of Paediatric Orthopaedics at the University of Vienna.
Mr Roposch is a member of the following professional bodies and societies:
Board Member, European Paediatric Orthopaedic Society
Chair, Scientific Committee, European Paediatric Orthopaedic Society
Member, British Society for Children's Orthopaedics
Member, Salter Society
Member, German-Speaking Society of Paediatric Orthopaedics
Research Interests
- development of diagnostic and disease severity indices
understanding disease progression and prognosis
patient-specific outcome measures
variations in care and clinical decision making
Ongoing research activities
Mr Roposch is leading a UK-wide study on the genetics of childhood hip dysplasia with over 15 participating centres. His group is also studying modulating factors and prognosis in neonatal hip dysplasias in a population based cohort study, and how parents make difficult decisions about operative treatment on behalf of their children.